SCHEMBL14547727

SCHEMBL14547727

COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CN)C[C@@H]3OC1CC(N)C(O)C(C)O1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.83
▸ THRB P10828 8/20 0.83
▸ KMT2A Q03164 8/20 0.83
▸ RECQL P46063 6/20 0.83
▸ BLM P54132 6/20 0.83
▸ HIF1A Q16665 6/20 0.83
▸ SMN1; SMN2 Q16637 6/20 0.83
▸ BRCA1 P38398 6/20 0.83
▸ TDP1 Q9NUW8 5/20 0.83
▸ MAPT P10636 5/20 0.83
▸ TOP2A P11388 4/20 0.83
▸ MAPK1 P28482 4/20 0.83
▸ STAT6 P42226 4/20 0.83
▸ CHRM1 P11229 3/20 0.83
▸ TBXA2R P21731 3/20 0.83
▸ KDM4E B2RXH2 3/20 0.83
▸ ALDH1A1 P00352 3/20 0.83
▸ ABCB1 P08183 3/20 0.83
▸ HTT P42858 3/20 0.83
▸ FYN P06241 2/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867452 0.95 MEN1 (0.84) MEN1THRBKMT2ARECQLBLM
SCHEMBL14547882 0.94 MEN1 (0.73) MEN1THRBKMT2ARECQLBLM
SCHEMBL10138466 0.94 MEN1 (0.81) MEN1THRBKMT2ARECQLBLM
SCHEMBL16015696 0.93 MEN1 (0.80) MEN1THRBKMT2ARECQLBLM
SCHEMBL26387964 0.93 MEN1 (0.80) MEN1THRBKMT2ARECQLBLM
SCHEMBL12462937 0.93 MEN1 (0.80) MEN1THRBKMT2ARECQLBLM
SCHEMBL20801118 0.93 MEN1 (0.88) MEN1THRBKMT2ARECQLBLM
SCHEMBL22513656 0.93 MEN1 (0.88) MEN1THRBKMT2ARECQLBLM
SCHEMBL14867492 0.93 MEN1 (0.88) MEN1THRBKMT2ARECQLBLM
SCHEMBL17899481 0.93 MEN1 (0.88) MEN1THRBKMT2ARECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093645-A1 Peptide vectors SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION (FR) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093645-A1 Peptide vectors TP53, VIP, XIAP MEN1 404/4885THRB 2283/4885KMT2A 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback